Review Articles

Strategies to optimize chimeric antigen receptor T-cell therapy in hematologic malignancies: Chinese experience

Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, People's Republic of China
Department of Hematology, Tongji Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China
Bone Marrow Transplantation Center, Institute of Hematology, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China
Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, People's Republic of China
Vol. 108 No. 8 (2023): August, 2023 https://doi.org/10.3324/haematol.2022.282316